Aclarion, Inc., a commercial-stage healthcare technology company, announced today that nearly 100 Nociscan procedures have been performed at The London Clinic, one of the UK's leading private hospitals. The company released a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon and Lead Clinician at The London Spine Clinic, who discusses his experience using Nociscan to evaluate patients with chronic low back pain.
Mr. Sutcliffe, with over 30 years of experience treating spinal conditions, noted that Nociscan provides an additional layer of insight that complements traditional imaging. “Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain,” he said in the video, which is available here.
Nociscan is a non-invasive diagnostic tool that uses MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain in the lumbar spine. It helps physicians differentiate between painful and non-painful discs, aiding in treatment planning. The continued use at The London Clinic reflects sustained physician engagement and growing integration into routine clinical practice.
Brent Ness, CEO of Aclarion, stated, “Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.” Chronic low back pain affects approximately 266 million people worldwide, and clinical data has shown up to a 97% surgical success rate when all Nociscan-positive discs are treated alongside other diagnostic tools.
For more information about Nociscan and to find a center, visit www.aclarion.com. The latest news and updates regarding Aclarion are available in the company’s newsroom at https://tinyurl.com/aconnewsroom.
